{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:34:50Z","timestamp":1777415690420,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Robotic Surg"],"DOI":"10.1007\/s11701-025-02768-6","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T17:52:23Z","timestamp":1757440343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Specimen extraction techniques utilized in minimally invasive surgery for uterine cancer and an enlarged uterus: a quality assurance study"],"prefix":"10.1007","volume":"19","author":[{"given":"Anna","family":"Quian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann Marie","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Wenham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Sook","family":"Chon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mian M.","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Yi","family":"Chern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchel S.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"issue":"4","key":"2768_CR1","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1097\/01.AOG.0000462977.61229.de","volume":"125","author":"Practice Bulletin No","year":"2015","unstructured":"Practice Bulletin No (2015) 149: Endometrial cancer. Obstet Gynecol 125(4):1006\u20131026. https:\/\/doi.org\/10.1097\/01.AOG.0000462977.61229.de","journal-title":"Obstet Gynecol"},{"issue":"8","key":"2768_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.6004\/jnccn.2025.0038","volume":"23","author":"NR Abu-Rustum","year":"2025","unstructured":"Abu-Rustum NR, Campos SM, Amarnath S, Arend R, Barber E, Bradley K, Brooks R, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R, Glaser S, Howitt BE, Landrum L, Lea J, Lee N, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Nieto K, Nwachukwu C, Podoll M, Rodabaugh K, Salani R, Schorge J, Schuetze S, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wyse E, McMillian N, Sambandam V (2025) NCCN guidelines\u00ae insights: uterine neoplasms, version 3.2025. J Nat Comp Cancer Net 23(8):284\u2013291. https:\/\/doi.org\/10.6004\/jnccn.2025.0038","journal-title":"J Nat Comp Cancer Net"},{"key":"2768_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/GMIT.GMIT_12_21","volume":"11","author":"K Chikazawa","year":"2022","unstructured":"Chikazawa K, Netsu S, Imai K, Kimura A, Kuwata T, Konno R (2022) Volume index is a risk factor for recurrence even in patients with clinical stage IA endometrial cancer undergoing either laparotomy or laparoscopy: A retrospective study. Gynecol Minim Invasive Ther 11:94\u201399","journal-title":"Gynecol Minim Invasive Ther"},{"issue":"1","key":"2768_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/GMIT.GMIT_82_19","volume":"9","author":"S Shanmugam","year":"2020","unstructured":"Shanmugam S, Thanikachalam R, Murugan A (2020) Comparative study of laparoscopic versus conventional open surgical staging procedure for endometrial cancer: our institutional experience. Gynecol Minim Invasive Ther 9(1):29\u201333","journal-title":"Gynecol Minim Invasive Ther"},{"issue":"4","key":"2768_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.tjog.2016.04.035","volume":"55","author":"CL Lee","year":"2016","unstructured":"Lee CL, Kusunoki S, Huang KG, Wu KY, Huang CY, Yen CF (2016) Long-term survival outcomes of laparoscopic staging surgery in treating endometrial cancer: 20 years of follow-up. Taiwan J Obstet Gynecol 55(4):545\u2013551. https:\/\/doi.org\/10.1016\/j.tjog.2016.04.035","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"1","key":"2768_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.gmit.2016.10.002","volume":"3","author":"S Shinohara","year":"2017","unstructured":"Shinohara S, Sakamoto I, Numata M, Ikegami A, Teramoto K (2017) Risk of spilling cancer cells during total laparoscopic hysterectomy in low-risk endometrial cancer. Gynecol Minim Invas Ther 3(1):113\u2013115","journal-title":"Gynecol Minim Invas Ther"},{"issue":"3","key":"2768_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ygyno.2012.05.023","volume":"126","author":"G Favero","year":"2012","unstructured":"Favero G, Anton C, Silva e Silva A, Ribeiro A, Ara\u00fajo MP, Miglino G, Baracat EC, Carvalho JP (2012) Vaginal morcellation: a new strategy for large gynecological malignant tumor extraction: a pilot study. Gynecol Oncol 126(3):443\u2013447. https:\/\/doi.org\/10.1016\/j.ygyno.2012.05.023","journal-title":"Gynecol Oncol"},{"issue":"6","key":"2768_CR8","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jmig.2015.04.015","volume":"22","author":"G Favero","year":"2015","unstructured":"Favero G, Miglino G, K\u00f6hler C, Pfiffer T, Silva e Silva A, Ribeiro A, Le X, Anton C, Baracat EC, Carvalho JP (2015) Vaginal morcellation inside protective pouch: a safe strategy for uterine extration in cases of bulky endometrial cancers: operative and oncological safety of the method. J Minim Invasive Gynecol 22(6):938\u2013943. https:\/\/doi.org\/10.1016\/j.jmig.2015.04.015","journal-title":"J Minim Invasive Gynecol"},{"issue":"3","key":"2768_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jmig.2011.12.019","volume":"19","author":"C Rivard","year":"2012","unstructured":"Rivard C, Salhadar A, Kenton K (2012) New challenges in detecting, grading, and staging endometrial cancer after uterine morcellation. J Minim Invasive Gynecol 19(3):313\u2013316. https:\/\/doi.org\/10.1016\/j.jmig.2011.12.019","journal-title":"J Minim Invasive Gynecol"},{"key":"2768_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40661-018-0065-1","volume":"5","author":"S Dotson","year":"2018","unstructured":"Dotson S, Landa A, Ehrisman J, Secord AA (2018) Safety and feasibility of contained uterine morcellation in women undergoing laparoscopic hysterectomy. Gynecol Oncol Res Pract 5:8. https:\/\/doi.org\/10.1186\/s40661-018-0065-1","journal-title":"Gynecol Oncol Res Pract"},{"issue":"6","key":"2768_CR11","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s00464-014-3422-0","volume":"28","author":"F Montella","year":"2014","unstructured":"Montella F, Riboni F, Cosma S, Dealberti D, Prigione S, Pisani C, Rovetta E (2014) A safe method of vaginal longitudinal morcellation of bulky uterus with endometrial cancer in a bag at laparoscopy. Surg Endosc 28(6):1949\u20131953. https:\/\/doi.org\/10.1007\/s00464-014-3422-0","journal-title":"Surg Endosc"},{"issue":"1","key":"2768_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jmig.2008.09.618","volume":"16","author":"G Condous","year":"2009","unstructured":"Condous G, Bignardi T, Alhamdan D, Van Calster B, Van Huffel S, Timmerman D, Lam A (2009) What determines the need to morcellate the uterus during total laparoscopic hysterectomy? J Minim Invasive Gynecol 16(1):52\u201355. https:\/\/doi.org\/10.1016\/j.jmig.2008.09.618","journal-title":"J Minim Invasive Gynecol"},{"issue":"2","key":"2768_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/gyn.2015.0079","volume":"32","author":"MS Hoffman","year":"2016","unstructured":"Hoffman MS, Ramirez I, Xiong Y (2016) Endometrial cancer: route of surgery. J Gynecol Surg 32(2):79\u201383. https:\/\/doi.org\/10.1089\/gyn.2015.0079","journal-title":"J Gynecol Surg"},{"issue":"3","key":"2768_CR14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ygyno.2014.11.014","volume":"136","author":"J Scalici","year":"2015","unstructured":"Scalici J, Laughlin BB, Finan MA, Wang B, Rocconi RP (2015) The trend towards minimally invasive surgery (MIS) for endometrial cancer: an ACS-NSQIP evaluation of surgical outcomes. Gynecol Oncol 136(3):512\u2013515. https:\/\/doi.org\/10.1016\/j.ygyno.2014.11.014","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2768_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.gyobfe.2016.01.008","volume":"44","author":"J Dubuisson","year":"2016","unstructured":"Dubuisson J, Veit-Rubin N (2016) Uterine volume and vaginal hysterectomy: Interest and limits of uterine morcellation. Gynecologie, Obstetrique & Fertilite 44(3):175\u2013180. https:\/\/doi.org\/10.1016\/j.gyobfe.2016.01.008","journal-title":"Gynecologie, Obstetrique & Fertilite"},{"key":"2768_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2017.00015","volume":"4","author":"E Taylan","year":"2017","unstructured":"Taylan E, Sahin C, Zeybek B, Akdemir A (2017) Contained morcellation: review of current methods and future directions. Front Surg 4:15. https:\/\/doi.org\/10.3389\/fsurg.2017.00015","journal-title":"Front Surg"}],"container-title":["Journal of Robotic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-025-02768-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11701-025-02768-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-025-02768-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T01:21:10Z","timestamp":1767489670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11701-025-02768-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2768"],"URL":"https:\/\/doi.org\/10.1007\/s11701-025-02768-6","relation":{},"ISSN":["1863-2491"],"issn-type":[{"value":"1863-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"H.S. Chon is on the advisory boards for Eisai and OncoInvent and receives honoraria from CCO. J.Y. Chern reports consulting fees from Curio Science, Equinox, and GSK; and speakers bureau payments from AstraZeneca, American Society of Health Systems Pharmacists, and Association of Community Cancer Center. R. Wenham reports consulting fees from Genentech, GSK\/Tesaro, AstraZeneca, AbbVie, Legend Biotech, Regeneron, Seagen, Shattuck Labs, Novocure, Mersana, Eisai, Merck, and Ovation Diagnostics; speaker fees from Clovis; traveling costs from Tapimmune, Eisai, and Sonnet Biotherapeutics; grants from Merck, OnTarget Labs, and Ovation Diagnostics; stock with Ovation Diagnostics; clinical trial funding and salary support from Anixa Biosciences; and is on the advisory board for Sonnet Biotherapeutics. The remaining authors declare that no funds, grants, or other support was received during the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was reviewed and approved by the Moffitt Cancer Center Scientific Review Committee on 07\/19\/2022. It is IRB exempt, study number MCC 21127.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"580"}}